ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Global Research Team Aims To Find Cause Of Chronic Fatigue Syndrome
Friday 19 June 2020
From European Pharmaceutical Manufacturer:
Global research team aims to find cause of Chronic Fatigue Syndrome
Data visualisation company Zegami is collaborating with an international team of medical researchers to try and find what causes Chronic Fatigue Syndrome (CFS).
The condition, also known as Myalgic Encephalomyelitis (ME) affects around 20 million people worldwide, but it is currently not clear what causes it. A range of complex symptoms make the condition difficult to diagnose and only 5% of patients make a full recovery.
The new project involving Zegami will be the largest of its kind in Europe, including three research centres in Oxford Bydgoszcz (Poland), and Valencia, over a four to five-year period. The team has secured $750,000 in funding from SoftCell Biologicals and is looking to raise an additional £1.6 million.
SoftCell Biologicals has recently developed a patent-pending protocol to culture and examine hidden bacteria in the circulatory system. Recent research into the cause of CFS/ME has been focused on the high levels of L-form bacteria found in patients’ blood, which suggests they may play a role in the condition.
The project will use Peripheral Blood Mononuclear Cell (PBMC) data obtained from the UK ME/CFS biobank, which includes samples of ME/CFS, Multiple Sclerosis and healthy control groups. Raman spectroscopy will then be used and visualised using Zegami’s software in order to differentiate between the three groups, and also identify trends and patterns.
It’s hoped that the project will help develop the first ever medical diagnostic test for ME/CFS and could even lead to new treatments or a cure.
blog comments powered by Disqus
Registered Charity 3104
PO Box 322,
South Australia 5092
1300 128 339
Monday - Friday,
10am - 4pm